Calcium channel blockers in the management of low-tension and open-angle glaucoma [1]

American Journal of Ophthalmology

Volumn 116, Issue 6, 1993, Pages 778-779

  Ettl, A ^a   Daxer, A ^a   Hofmann, U ^a   Netland, P A ^a   Chaturvedi, N ^a   Dreyer, E B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; EYE DROPS; VERAPAMIL;

AQUEOUS HUMOR; CATARACT; DRUG BLOOD LEVEL; HUMAN; HYPERTENSION; INTRAOCULAR HYPERTENSION; LETTER; LOW TENSION GLAUCOMA; NONHUMAN; OPEN ANGLE GLAUCOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

EID: 0027515611     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9394(14)73489-0     Document Type: Letter

References (5)

1. M.B. Abelson L.M. Smith Sustained reduction of intraocular pressure in humans with the calcium channel blocker verapamil Am. J. Ophthalmol. 105 1988 155
2. M.L. Mooshian L.M. Leonardi G.L. Schooley K. Erickson J.V. Greiner One drop study to evaluate safety and efficacy of an ophthalmic calcium channel blocker, verapamil, in subjects with elevated intraocular pressure Invest. Ophthalmol. Vis. Sci. 34 Suppl. 1993 924
3. Ettl, A., Dietrich, H., Hofmann, U., Daxer, A., Schmid E., and Eichelbaum, M.: Ocular penetration and elimination of verapamil hydrochloride. Doc. Ophthalmol. In press.
4. A. Schroder K.A. Erickson Verapamil increases facility of outflow in the human eye in vitro Invest. Ophthalmol. Vis. Sci. 34 Suppl. 1993 924
5. A. Fleckenstein Prevention by verapamil of arterial calcium overload and concomitant lenticular calcification causing cataracts in alloxan-diabetic rats A. Fleckenstein Calciumantagonism in Heart and Smooth Muscle 1984 J. Wiley New York 280 285